Bionik Laboratories (OTCMKTS:BNKL) Share Price Crosses Above 50-Day Moving Average – Here’s Why

Bionik Laboratories Corp. (OTCMKTS:BNKL – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0001. Bionik Laboratories shares last traded at $0.00, with a volume of 0 shares changing hands.

Bionik Laboratories Price Performance

Get Bionik Laboratories alerts:

Bionik Laboratories Company Profile

(Get Free Report)

Bionik Laboratories Corp., headquartered in Waltham, Massachusetts, designs, develops and markets robotics-based rehabilitation solutions and assistive devices for patients with neurological and mobility impairments. Its core product portfolio includes the ARKE lower limb exoskeleton for gait training and the InMotion series of upper extremity robotic therapy devices, such as InMotion ARM and InMotion WRIST. These systems leverage sensor-driven feedback and proprietary software to enable clinicians to deliver personalized motor rehabilitation programs.

Founded in 2008, Bionik established a foundation in exoskeleton and robotics technology before expanding its clinical product suite through strategic acquisitions and research collaborations.

Featured Articles

• Five stocks we like better than Bionik Laboratories
• Credo Technologies Accelerates AI—Its Stock Price Will Follow
• Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
• Jabil Just Gave Investors a Stronger Reason to Buy the Dip
• CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge

Receive News & Ratings for Bionik Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionik Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.